10-K: Hercules Capital, Inc. Outlines Securities and Corporate Governance in 10-K Filing

Sentiment:

Annual Results


Hercules Capital, Inc. details its registered securities, capital stock, and corporate governance practices in its annual 10-K filing.

Summary

  • Hercules Capital, Inc. has three classes of securities registered under the Securities Exchange Act of 1934: common stock and 6.25% notes due in 2033.
  • The company's authorized capital stock consists of 200,000,000 shares of common stock with a par value of $0.001 per share.
  • The Board of Directors can classify and reclassify unissued shares without stockholder approval, subject to the Investment Company Act of 1940.
  • Stockholders are generally not personally liable for the company's debts or obligations.
  • Common stock shares have equal rights to earnings, assets, distributions, and voting privileges.
  • The company's charter includes provisions limiting the liability of directors and officers, and provides for indemnification and advance of expenses.
  • The Board of Directors is divided into three classes serving staggered three-year terms.
  • Stockholder action can only be taken at an annual or special meeting or by unanimous consent.
  • The company's bylaws require advance notice for stockholder nominations and proposals.
  • Special meetings of stockholders can be called by the Board, certain officers, or by a majority of stockholders.
  • Extraordinary corporate actions require approval by a majority of stockholders, with certain amendments requiring 75% approval.
  • The company is subject to the Maryland Control Share Acquisition Act and the Maryland Business Combination Act, but has opted out of certain provisions.
  • The company's wholly-owned subsidiary, HC IV, has an SBIC license and is subject to SBA regulations.
  • The 6.25% notes due in 2033 were issued on September 24, 2018, with a principal amount of $40.0 million and mature on October 30, 2033.
  • The company is in compliance with the terms of the 2033 Notes Indenture as of December 31, 2023.
  • The indenture does not limit the amount of debt securities that may be issued.
  • The company has agreed to deliver to the Trustee an Officers Certificate stating whether the Company is in default in the performance of any of the terms, provisions or conditions of the indenture.
  • The company has agreed to comply with certain provisions of the 1940 Act regarding asset coverage and dividend declarations.
  • The debt securities were issued as registered securities in book-entry form only.
  • The company has the ability to issue debt securities with terms different from those of debt securities previously issued.
  • The company may redeem some or all of the 2033 Notes at any time, or from time to time, at the redemption price set forth under the terms of the indenture after October 30, 2023.

Sentiment

Score: 7

Explanation: The document is a factual and detailed regulatory filing, which is generally neutral in sentiment. However, the company's compliance with regulations and its ability to issue debt securities are positive indicators.

Positives

  • The company has a well-defined capital structure with a significant number of authorized common shares.
  • The company has a clear process for issuing debt securities.
  • The company has a strong corporate governance framework with provisions for director and officer protection.
  • The company is in compliance with the terms of the 2033 Notes Indenture.
  • The company has the ability to issue debt securities with terms different from those of debt securities previously issued.

Negatives

  • Stockholder action can only be taken at an annual or special meeting or by unanimous consent, which may limit stockholder influence.
  • The company is subject to the Maryland Control Share Acquisition Act and the Maryland Business Combination Act, which may make it more difficult for a potential acquirer to acquire the company.
  • The company's wholly-owned subsidiary, HC IV, has an SBIC license and is subject to SBA regulations, which may limit its flexibility.

Risks

  • The Board of Directors can classify and reclassify unissued shares without stockholder approval, which may dilute existing stockholders.
  • The company's charter includes provisions limiting the liability of directors and officers, which may reduce accountability.
  • The company is subject to the Maryland Control Share Acquisition Act and the Maryland Business Combination Act, which may make it more difficult for a potential acquirer to acquire the company.
  • The company's wholly-owned subsidiary, HC IV, has an SBIC license and is subject to SBA regulations, which may limit its flexibility.
  • The company may redeem some or all of the 2033 Notes at any time, or from time to time, at the redemption price set forth under the terms of the indenture after October 30, 2023, which may impact noteholders.

Future Outlook

The document does not contain any specific future outlook statements, but it does outline the company's ongoing compliance with regulations and its ability to issue debt securities.

Management Comments

  • The Board of Directors is authorized to classify and reclassify any unissued shares of stock into other classes or series of stock, and to cause the issuance of such shares, without obtaining stockholder approval.
  • The Board of Directors, without any action by our stockholders, may amend the charter from time to time to increase or decrease the aggregate number of shares of stock or the number of shares of stock of any class or series that we have authority to issue.

Industry Context

This document is a standard 10-K filing, which is a routine part of the regulatory landscape for publicly traded companies. It provides transparency to investors regarding the company's financial and operational status.

Comparison to Industry Standards

  • The company's capital structure and governance practices are generally consistent with other publicly traded BDCs.
  • The company's debt securities are similar to those issued by other BDCs, with a focus on unsecured debt.
  • The company's compliance with the 1940 Act and other regulations is a standard requirement for BDCs.
  • The company's use of an SBIC subsidiary is a common practice among BDCs seeking to leverage SBA funding.

Stakeholder Impact

  • Stockholders are provided with detailed information about the company's securities and governance.
  • Creditors are provided with information about the company's debt obligations and compliance.
  • Employees are subject to the company's code of ethics and are provided with information about their responsibilities.

Next Steps

  • The company will continue to comply with the terms of the 2033 Notes Indenture.
  • The company will continue to monitor and comply with all applicable regulations.
  • The company may issue additional debt securities in the future.

Key Dates

DateDescription
March 6, 2012Date of the Base Indenture.
September 24, 2018Date of issuance of the 6.25% Notes due 2033.
October 30, 2023Date after which the company may redeem some or all of the 2033 Notes.
December 31, 2023Date of the financial statements and the end of the fiscal year.

Keywords

securities, common stock, debt securities, corporate governance, board of directors, indemnification, investment company act, SBIC, notes, indenture

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.